Blood donation study for warfarin patients
Part of Heart & circulation, Lungs & breathing clinical trials.
This study collects blood samples from people who take warfarin to help improve monitoring of the medication. It is designed for patients who are stable on warfarin and want to contribute to research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking warfarin (a blood thinner).
- You are 18 years old or older.
- You have not taken any other blood thinner like heparin in the last 7 days.
- You do not have or are not suspected of having antiphospholipid syndrome.
- You are not pregnant and have not been pregnant in the past year.
- You do not have HIV/AIDS, hepatitis A, B, or C, tuberculosis, a tropical disease, or use intravenous drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This study collects blood samples from people already taking part in the OCEANIC-AF trial. It aims to learn more about the effects of the treatment being tested.
This study collects blood samples from people with various health conditions to help researchers develop and improve new diagnostic tests. If you have certain symptoms or conditions like blood clots, infections, heart problems, diabetes, or others, you may be able to take part.
This study collects small blood samples to help test and improve new diagnostic devices. You may be eligible if you’re an adult with certain symptoms that match one of several health “groups,” and if you can consent and read English.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
Hear when a new Pulmonary Embolism (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.